Cerebral contusion

EISAI SUBMITS MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER'S DISEASE IN EUROPE

Retrieved on: 
Tuesday, January 10, 2023

Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.

Key Points: 
  • Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.
  • There are no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied.
  • Depending on ARIA severity, use clinical judgment in considering whether to continue dosing, temporarily discontinue treatment, or permanently discontinue LEQEMBI.
  • In Study 1, 15% of LEQEMBI-treated patients, compared to 6% of placebo-treated patients, stopped study treatment because of an adverse reaction.

Survivor of Life-Threatening Brain Surgery Shares His Story of Hope, Resilience and Recovery in Inspirational New Memoir

Retrieved on: 
Monday, October 19, 2020

As the tumor grew, he had no choice but to have brain surgery bringing tremendous fear to Plaskas and his family.

Key Points: 
  • As the tumor grew, he had no choice but to have brain surgery bringing tremendous fear to Plaskas and his family.
  • During the operation Plaskas suffered a brain hemorrhage, losing a massive amount of blood and was placed in a medically induced coma.
  • Plaskas details the emotional and physical toll his life-threatening brain surgery brought him and how he was able to overcome obstacles the brain injury had caused.
  • I want people to know a severe brain injury survivor can accomplish many recovery goals if they have confidence, determination and hard work, said Plaskas.